Condition: Esophageal Cancer
Interventions: Drug: SHR-1210; Radiation: IMRT or VMAT; Drug: Apatinib
Sponsors: Tianjin Medical University Cancer Institute and Hospital; Jiangsu HengRui Medicine Co., Ltd.
Not yet recruiting
https://ift.tt/2MvyUNv
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
Ετικέτες
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Summary Insulinomas are rare neuroendocrine tumours that classically present with fasting hypoglycaemia. This case report discusses an un...
-
The online platform for Taylor & Francis Online content New for Canadian Journal of Remote Sen...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου